Reappraisal of esophagogastrectomy for esophageal malignancy.

Esophagogastrectomy performed in eighty-three patients with a thirty day mortality of 7 per cent, a resectability rate of 93 per cent, and no anastomotic leakage, provided dependable relief of malignant obstruction and restored oral alimentation in all surviving patients. Long-term survival was unchanged. The successful resection of all midthird lesions with a 3.9 per cent mortality reflects the capability of current surgery and suggests that surgical palliation of midthird esophageal tumors is preferable to radiotherapy alone.